1. Home
  2. EIG vs HROW Comparison

EIG vs HROW Comparison

Compare EIG & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

N/A

Current Price

$47.67

Market Cap

928.6M

Sector

Finance

ML Signal

N/A

HROW

Harrow Inc.

N/A

Current Price

$27.51

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EIG
HROW
Founded
2000
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
928.6M
1.0B
IPO Year
2006
2008

Fundamental Metrics

Financial Performance
Metric
EIG
HROW
Price
$47.67
$27.51
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$54.00
★ $63.00
AVG Volume (30 Days)
143.7K
★ 544.1K
Earning Date
10-28-2026
11-09-2026
Dividend Yield
★ 2.88%
N/A
EPS Growth
N/A
★ 71.43
EPS
★ 2.73
N/A
Revenue
★ $858,700,000.00
N/A
Revenue This Year
N/A
$28.41
Revenue Next Year
N/A
$58.14
P/E Ratio
$17.35
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$37.44
$25.76
52 Week High
$53.51
$54.98

Technical Indicators

Market Signals
Indicator
EIG
HROW
Relative Strength Index (RSI) 42.59 41.61
Support Level $41.49 $26.96
Resistance Level $51.18 $30.28
Average True Range (ATR) 1.79 1.31
MACD -0.39 0.07
Stochastic Oscillator 34.41 41.37

Price Performance

Historical Comparison
EIG
HROW

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: